0001225208-22-002932.txt : 20220222 0001225208-22-002932.hdr.sgml : 20220222 20220222164651 ACCESSION NUMBER: 0001225208-22-002932 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220217 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pierce David A CENTRAL INDEX KEY: 0001529751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 22658931 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2022-02-17 0000885725 BOSTON SCIENTIFIC CORP BSX 0001529751 Pierce David A 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP Pres MedSurg Common Stock 2022-02-17 4 M 0 3333.0000 0.0000 A 3333.0000 D Common Stock 2022-02-17 4 F 0 979.0000 42.8300 D 2354.0000 D Common Stock 2022-02-18 4 M 0 2668.0000 0.0000 A 5022.0000 D Common Stock 2022-02-18 4 F 0 784.0000 42.5500 D 4238.0000 D Common Stock 2022-02-18 4 S 0 2354.0000 42.8800 D 1884.0000 D Restricted Stock Units 2022-02-17 4 M 0 3333.0000 0.0000 D 2025-02-17 Common Stock 3333.0000 10000.0000 D Deferred Stock Units 2022-02-18 4 M 0 2668.0000 0.0000 D 2024-02-18 Common Stock 2668.0000 5337.0000 D Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2022-02-19